메뉴 건너뛰기
Lung Cancer
Volumn 60, Issue 2, 2008, Pages 294-297
Retreatment with pemetrexed-based chemotherapy in malignant pleural mesothelioma (MPM): A second line treatment option
Author keywords

Chemotherapy; Mesothelioma; Pemetrexed; response; Retreatment; Second line
Indexed keywords

CARBOPLATIN; CISPLATIN; PEMETREXED;
EID: 42949099359     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.08.031     Document Type: Article
Times cited : (24)
References (5)
  • 1
    • 20244374653 scopus 로고    scopus 로고
    • Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma
    • Hughes A., Calvert P., Azzabi A., Plummer R., Johnson R., Rusthoven J., et al. Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma. J Clin Oncol 20 16 (2002) 3533-3544
    • (2002) J Clin Oncol , vol.20 , Issue.16 , pp. 3533-3544
    • Hughes, A.1    Calvert, P.2    Azzabi, A.3    Plummer, R.4    Johnson, R.5    Rusthoven, J.6
  • 2
    • 0041629528 scopus 로고    scopus 로고
    • Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
    • Vogelzang N.J., Rusthoven J.J., Symanowski J., Denham C., Kaukel E., Ruffie P., et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21 14 (2003) 2636-2644
    • (2003) J Clin Oncol , vol.21 , Issue.14 , pp. 2636-2644
    • Vogelzang, N.J.1    Rusthoven, J.J.2    Symanowski, J.3    Denham, C.4    Kaukel, E.5    Ruffie, P.6
  • 3
    • 27244447448 scopus 로고    scopus 로고
    • Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada
    • van Meerbeeck J.P., Gaafar R., Manegold C., Van Klavaren R.J., Van Marck E.A., Vincent M., et al. Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. J Clin Oncol 23 28 (2005) 6881-6889
    • (2005) J Clin Oncol , vol.23 , Issue.28 , pp. 6881-6889
    • van Meerbeeck, J.P.1    Gaafar, R.2    Manegold, C.3    Van Klavaren, R.J.4    Van Marck, E.A.5    Vincent, M.6
  • 4
    • 21344471421 scopus 로고    scopus 로고
    • Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma
    • Manegold C., Symanowski J., Gatzemeier U., Reck M., von Powel J., Kortsik C., et al. Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma. Ann Oncol 16 6 (2005) 923-927
    • (2005) Ann Oncol , vol.16 , Issue.6 , pp. 923-927
    • Manegold, C.1    Symanowski, J.2    Gatzemeier, U.3    Reck, M.4    von Powel, J.5    Kortsik, C.6
  • 5
    • 0032772821 scopus 로고    scopus 로고
    • Gemcitabine and cisplatin: second-line chemotherapy for malignant mesothelioma?
    • Vogelzang N.J. Gemcitabine and cisplatin: second-line chemotherapy for malignant mesothelioma?. J Clin Oncol 17 8 (1999) 2626-2627
    • (1999) J Clin Oncol , vol.17 , Issue.8 , pp. 2626-2627
    • Vogelzang, N.J.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.